BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 32429384)

  • 1. Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.
    Ciesielski O; Biesiekierska M; Balcerczyk A
    Molecules; 2020 May; 25(10):. PubMed ID: 32429384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
    Nandakumar V; Vaid M; Katiyar SK
    Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
    Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
    Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation.
    Nightingale KP; Gendreizig S; White DA; Bradbury C; Hollfelder F; Turner BM
    J Biol Chem; 2007 Feb; 282(7):4408-4416. PubMed ID: 17166833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental exposure to 50 parts-per-billion arsenic influences histone modifications and associated epigenetic machinery in a region- and sex-specific manner in the adult mouse brain.
    Tyler CR; Hafez AK; Solomon ER; Allan AM
    Toxicol Appl Pharmacol; 2015 Oct; 288(1):40-51. PubMed ID: 26193056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.
    Deb G; Shankar E; Thakur VS; Ponsky LE; Bodner DR; Fu P; Gupta S
    Mol Carcinog; 2019 Jul; 58(7):1194-1207. PubMed ID: 30854739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of histone deacetylase 4, -5 and -6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin.
    Oya Y; Mondal A; Rawangkan A; Umsumarng S; Iida K; Watanabe T; Kanno M; Suzuki K; Li Z; Kagechika H; Shudo K; Fujiki H; Suganuma M
    J Nutr Biochem; 2017 Apr; 42():7-16. PubMed ID: 28103535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases.
    Thakur VS; Gupta K; Gupta S
    Int J Oncol; 2012 Jul; 41(1):353-61. PubMed ID: 22552582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay of histone modifications - writers that read.
    Zhang T; Cooper S; Brockdorff N
    EMBO Rep; 2015 Nov; 16(11):1467-81. PubMed ID: 26474904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells.
    Borutinskaitė V; Virkšaitė A; Gudelytė G; Navakauskienė R
    Leuk Lymphoma; 2018 Feb; 59(2):469-478. PubMed ID: 28641467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic aspects of HP1 exchange kinetics in apoptotic chromatin.
    Legartová S; Jugová A; Stixová L; Kozubek S; Fojtová M; Zdráhal Z; Lochmanová G; Bártová E
    Biochimie; 2013 Feb; 95(2):167-79. PubMed ID: 23023195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
    Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
    Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
    Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
    Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGCG prevents pressure overload‑induced myocardial remodeling by downregulating overexpression of HDAC5 in mice.
    Han X; Peng C; Huang L; Luo X; Mao Q; Wu S; Zhang H
    Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34841436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
    Berletch JB; Liu C; Love WK; Andrews LG; Katiyar SK; Tollefsbol TO
    J Cell Biochem; 2008 Feb; 103(2):509-19. PubMed ID: 17570133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Histone Methylation in Cancer.
    McCabe MT; Mohammad HP; Barbash O; Kruger RG
    Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone modification therapy of cancer.
    Biancotto C; Frigè G; Minucci S
    Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of histone modifications and variants in regulating gene expression in breast cancer.
    Dalvai M; Bystricky K
    J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):19-33. PubMed ID: 20131086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.